Clinical Trial: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: OBSERVATIONAL




Official Title: A Multicenter Observational Study for Ex-vivo Evaluation of the Likelihood of Response to an Experimental Tolerance Restoration Therapy in Subjects Diagnosed With Multiple Sclerosis (MS)

Brief Summary: All males and females between 18-70 years of age regardless of their race and ethnicity with a confirmed diagnosis of Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), and Relapse Remitting Multiple Sclerosis (RRMS) are invited to participate in this Observational study being conducted across four sites in the US.
Since this is an observational study no medication/drug or treatment will be given to the participants.
The investigator will be collecting information about the participant's MS disease, its progression, current medications, radiographic scans, and blood samples.
This will help the investigator evaluate the biomarkers and new treatment options to better understand the MS disease process.